Google (NASDAQ:GOOG): Sterne Agee says that the search giant will most likely post mixed Q1 results, following supplier checks and data point reviews. The firm slightly raised its estimates, but is expected a lower than anticipated Q1 EPS, citing a shift towards lower margin areas. It maintains a Neutral rating on Google, but expects revenue to beat predictions.
Monsanto (NYSE:MON): Morgan Stanley is optimistic after a trip to Brazil, where increased interest among Brazilian farmers for Monsanto’s Intacta soybeans have raised their willingness to purchase it given the successful field rates. The firm maintains rates the company at Overweight with a $125 price target.
Zogenix (NASDAQ:ZGNX): Wells Fargo says that Zogenix may benefit from the FDA’s stance on opioid patents, following a ban on generic versions of oxycontin. The firm isoptimisticon the company’s position in this scenario, and keeps an Outperform on its shares.
WESCO (NYSE:WCC): Oppenheimer is bullish and confident that WESCO is well poised to benefit significantly from a non-residential construction upswing, while its valuation is “depressed.” The firm sees Q1 headwinds as “noise” for a buying opportunity, and keeps its Outperform rating on the stock.